Rylea setelah Perawatan Sel Punca di Tiongkok - Beike Biotech | Hipoplasia Saraf Optik | Perawatan Sel Punca Tiongkok

Rylea setelah Perawatan Sel Punca di Tiongkok - Beike Biotech

Beike Biotech, Sel Punca, Penelitian Sel Punca, Sel Punca Embrionik, Terapi Sel Punca, Terapi Sel Punca Dewasa, Terapi Sel Punca Embrionik, Terapi Sel Punca untuk Autisme, Pengobatan Hipoplasia Saraf Optik

Category: Stem Cell Therapy
Country: China
Procedure: Stem Cell Therapy
Source: Action 12 News | You Tube

Berita Action 12 menampilkan Rylea Bartlett setelah dia kembali ke rumah usai menerima perawatan sel punca di China dan berbagai kemajuan yang dialaminya.

Silakan Klik di sini untuk meminta informasi lebih lanjut dari Beike Biotech.

Rylea setelah Perawatan Sel Punca di Tiongkok - Beike Biotech | Hipoplasia Saraf Optik | Perawatan Sel Punca Tiongkok

Popular Medical Centers

PlacidWay China Medical Tourism is here to help you find the best medical option for you abroad, at affordable prices and performed with the latest medical technology. Contact us and we can offer a personalized medical option according to your needs and desires for FREE.

Beijing Puhua International Hospital (BPIH), located in the heart of Beijing's cultural center, has been delivering international-standard healthcare since 1995. Learn about the stem-cell and cancer hospital here.

  • Stem Cell Treatment for Diabetes from $15710
  • Stem Cell Treatment for Autism from $17000
  • Stem Cell Therapy for Brain Injury from $21425
  • Stem Cell Treatment for Epilepsy from $21425
  • Stem Cell Treatment for Multiple Sclerosis from $29280
  • Stem Cell Treatment for Muscular Dystrophy from $27140

Founded in 1986, Shijiazhuang Hetaiheng Kidney Hospital is a specialty hospital for kidney disease with traditional Chinese medicine (TCM).

A large number of people are being diagnosed with type 1 diabetes and the numbers are rapidly increasing over time. Beijing Puhua International Hospital brings the best treatment of diabetes with stem cell therapy in Beijing, China.